Nigral and striatal comparative study of the neurotoxic action of 1-methyl-4-phenylpyridinium ion: Involvement of dopamine uptake system

Journal of Neurochemistry

Volumn 66, Issue 3, 1996, Pages 1182-1190

  Santiago, Marti ^a   Machado, Alberto ^a   Cano, Josefina ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

1 Methyl 4 phenylpyridinium ion; Dopamine; Microdialysis; Rat; Striatum; Substantia nigra

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; DOPAMINE; NOMIFENSINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; MALE; MICRODIALYSIS; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 0030041125     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66031182.x     Document Type: Article

References (30)

1. Burns R. S., Chieuh C. C., Markey S. P., Ebert S. P., Jacobowitz D. M., and Kopin I. (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80, 4546-4550.
2. Chiba K., Trevor A., and Castagnoli N. Jr. (1984) Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res Commun. 120, 574-578.
3. Forno L. S., DeLanney L. E., Irwin I., and Langston J. W. (1994) Evolution of nerve fiber degeneration in the striatum in the MPTP-treated squirrel monkey. Mol. Neurobiol. 9, 163-170.
4. Fuller R. W. and Hemrick-Luecke S. K. (1985) Effects of amfonelic acid, alphamethyltyrosine, Ro 4-1284 and haloperidol on the depiction of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Res. Commun. Chem. Pathol. Pharmacol. 48, 17-25.
5. Hornykiewicz O. (1966) Dopamine (3-hydroxytryptamine) and brain function. Pharmacol Rev. 18, 925-963.
6. Javitch J. A., Uhl G. R., and Snyder S. H. (1984) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: characterization and localization of receptor binding sites in rat and human brain. Proc. Natl. Acad. Sci. USA 81, 4591-4595.
7. Javitch J. A., D'Amato R. J., Strittmatter S. M., and Snyder S H. (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA 82, 2173-2177.
8. Jones S. R., Garris P. A., Kilts C. D., and Wightman R. M. (1995) Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudate-putamen, and nucleus accumbens of the rat. J. Neurochem. 64, 2581-2589.
9. + administration. Eur. J. Pharmacol. 175, 57-61.
10. Martin F. R., Sanchez-Ramos J., and Rosenthal M. (1991) Selective and nonselective effects of 1-methyl-4-phenylpyridinium on oxygen consumption in rat striatal and hippocampal slices. J. Neurochem. 57, 1340-1346.
11. Mayer R. A., Kindt M. V., and Heikkila R. E. (1986) Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport. J. Neurochem. 47, 1073-1079.
12. Melamed E., Rosenthal J., Cohen O., Globus M., and Uzzan A. (1985) Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP. Eur. J. Pharmacol. 63, 216-220.
13. Nomikos G. G., Damsma G., Wenkstern D., and Fibiger H. C. (1990) In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Synapse 6, 106-112.
14. Parkinson J. (1817) An Essay on the Shaking Palsy. London.
15. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
16. Pifl C., Giros B., and Caron M. G. (1993) Dopamine transporter expression confers cytotoxicity to low-doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. J. Neurosci. 13, 4246-4253.
17. Pileblad E. and Carlsson A. (1985) Catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain. Neuropharmacology 24, 689-692.
18. +) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase. J. Neurochem. 56, 1184-1190
19. +-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies. J. Pharmacol. Exp. Ther. 268, 380-387.
20. Sanchez-Ramos J. R., Song S. J., Mash D. C., and Weiner W. J. (1992) 21-Aminosteroids interact with the dopamine transporter to protect against 1-methyl-4-phenylpyridinium-induced neurotoxicity. J. Neurochem. 58, 328-334.
21. Santiago M. and Westerink B. H. C. (1990) Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes. Naunyn Schmiedebergs Arch. Pharmacol. 342, 407-414.
22. Santiago M., Westerink B. H. C., and Rollema H. (1991) Responsiveness of striatal dopamine release in awake animals after chronic 1-methyl-4-phenylpyridinium ion-induced lesions of the substantia nigra. J. Neurochem. 56, 1336-1342.
23. + neurotoxicity by N-methyl-D-aspartate antagonists. Brain Res. 586, 203-207.
24. +-induced cell injury in the striatum of rats. Br. J. Pharmacol. 111, 837-842.
25. Sziráki I., Kardos V., Patthy M., Pátfalusi M., and Budai G. (1994) Methamphetamine protects against MPTP neurotoxicity in C57BL mice. Eur. J. Pharmacol. 251, 311-314.
26. Takada M., Li Z. K., and Hattori T. (1990) Astroglial ablation prevents MPTP-induced nigrostriatal neuronal death. Brain Res. 509, 55-61.
27. Veneto J. L., Machado A., and Cano J. (1991a) Age effects on monoamine turnover of the rat substantia nigra. Brain Res. 557, 109-114.
28. Venero J. L., Machado A., and Cano J. (1991b) Turnover of dopamine and serotonin and their metabolites in the striatum of aged rats. J. Neurochem. 56, 1940-1948.
29. Westerink B. H. C., Damsma G., Rollema H., de Vries J. B., and Horn A. S. (1987) Scope and limitations of in vivo brain dialysis: a comparison of its applications to various neurotransmitter systems. Life Sci. 41, 1763-1776.
30. Zetterström T., Sharp T., Collin A. K., and Ungerstedt U. (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs: implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148, 327-334.